Jardiance is the first SGLT2-inhibitor therapy to prove reduction in risk of cardiovascular death in people with type-II diabetes and established cardiovascular disease
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
Taluka level transplant centre will add convenience to patients from rural areas
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Nelarabine is in a class of medications called antimetabolites
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
Subscribe To Our Newsletter & Stay Updated
